Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Cancer of Kidney

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Cancer of Kidney in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alsaeedi, N; Bandaru, VV; Chatterjee, S; Halushka, MK; Haughey, NJ; Hou, J; Ndikuyeze, G; Pili, R; Wu, L	1

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Cancer of Kidney

Article	Year
Use of a glycolipid inhibitor to ameliorate renal cancer in a mouse model. PloS one, 2013, Volume: 8, Issue:5 Topics: Administration, Oral; Animals; Antigens, CD; Blotting, Western; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Galactosyltransferases; Glucosylceramides; Glucosyltransferases; Kidney; Kidney Neoplasms; Lactosylceramides; Mice; Mice, Inbred BALB C; Morpholines; Peptide Fragments; Proto-Oncogene Proteins c-akt; Signal Transduction; Time Factors; Transcription Factors; Treatment Outcome; Tumor Burden; Tumor Suppressor Protein p53	2013

Article

Year

Use of a glycolipid inhibitor to ameliorate renal cancer in a mouse model.

PloS one, 2013, Volume: 8, Issue:5

Topics: Administration, Oral; Animals; Antigens, CD; Blotting, Western; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Galactosyltransferases; Glucosylceramides; Glucosyltransferases; Kidney; Kidney Neoplasms; Lactosylceramides; Mice; Mice, Inbred BALB C; Morpholines; Peptide Fragments; Proto-Oncogene Proteins c-akt; Signal Transduction; Time Factors; Transcription Factors; Treatment Outcome; Tumor Burden; Tumor Suppressor Protein p53

2013